New Research Triangle Company Provides Innovative Global Services To The Pharmaceutical Industry
The Research Triangle is no stranger to the pharmaceutical industry, but newcomer Clintrax Global, Inc. is changing how the industry thinks about clinical trial contract negotiations.
The Research Triangle is no stranger to the pharmaceutical industry, but newcomer Clintrax Global, Inc. is changing how the industry thinks about clinical trial contract negotiations.
Clintrax Global opened for business in January 2013, with a mission to improve the way clinical trial contracts and budgets are negotiated. The company specializes as a functional service provider for pharmaceutical/biotechnology companies and contract research organizations (CROs) during the process of drug development. Clintrax provides these clients with worldwide contract and budget negotiation services with clinical trial sites including small clinics, large hospitals, and multicenter academic institutions.
Clintrax Global's unique business model is based on a seamless, centrally managed global footprint of in-country legal negotiators, which allows the company to execute agreements in over 60 countries in their local languages, and in accordance with each country's specific legal, regulatory and customary requirements. The company focuses on shortening negotiation times in order to minimize costly delays in the conduct of clinical trials. The sooner contracts are negotiated, the sooner the site can begin trial enrollment and provide knowledge about the drug.
Clintrax Global also offers a unique cloud-based tracking and reporting system, which allows clients to monitor and track the contract negotiation process in real time. This transparency gives clients the ability to ascertain the status of any individual contract throughout its life cycle.
Though the company is new, it brings together a team with years of experience, expertise, and success in clinical contracts. "Our personnel's breadth of local legal and budget negotiation experience in clinical trials allows us the flexibility to adapt to each client's needs on a global basis in order to quickly negotiate contracts while maintaining a high level of quality," says Clintrax Global Vice President of Operations, Elizabeth Easley. Clintrax Global endeavors to transform the contract negotiation service model in the clinical trial industry and looks forward to growth as the world's leading functional service provider for clinical trial contract negotiations.
Call Colin Dietch, (919) 322-2398 for more information.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
